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ABSTRACT
Objectives: Diabetes requires continuous medical
care including prevention of acute complications and
risk reduction for long-term complications. Diabetic
complications impose a substantial burden on public
health and care delivery. We examined trends in
regional differences in hospitalisations due to diabetes-
related complications among the total diabetes
population in Finland.
Research design: A longitudinal register-based
cohort study 1996−2011 among a total population
with diabetes in Finland.
Participants: All persons with diabetes identified from
several administrative registers in Finland in 1964
−2011 and alive on 1 January 1996.
Outcome measures: We examined hospitalisations
due to diabetes-related short-term and long-term
complications, uncomplicated diabetes, myocardial
infarction, stroke, lower extremity amputation and
end-stage renal disease (ESRD). We calculated annual
age-adjusted rates per 10 000 person years and the
systematic component of variation. Multilevel models
were used for studying time trends in regional
variation.
Results: There was a steep decline in complication-
related hospitalisation rates during the study period.
The decline was relatively small in ESRD (30%),
whereas rates of hospitalisations for short-term and
long-term complications as well as uncomplicated
diabetes diminished by about 80%. The overall
correlation between hospital district intercepts and
slopes in time was −0.72 (p<0.001) among men and
−0.99 (p<0.001) among women indicating diminishing
variation. Diminishing variation was found in each of
the complications studied. The variation was mainly
distributed at the health centre level.
Conclusions: Our study suggests that the prevention
of complications among persons with diabetes has
improved in Finland between 1996 and 2011. The
results further suggest that the prevention of
complications has become more uniform throughout
the country.
INTRODUCTION
The diabetic population is growing world-
wide. An epidemic expansion of type 2 dia-
betes has been considered to be the main
contributor to the increase in European
countries including Finland.1 2 There has
been a major increase in type 1 diabetes as
well in Finland.2 3 As a complex chronic
disease, diabetes requires continuous medical
care including multifactorial risk reduction,
supporting patient self-management, preven-
tion of acute complications and reduction of
the risk of long-term complications.4 The inci-
dence of macrovascular complications (myo-
cardial infarction (MI) and stroke) in the
diabetic population is decreasing according
to several studies.5 6 In microvascular compli-
cations like end-stage renal disease (ESRD), a
Strengths and limitations of this study
▪ Our register-based data cover the total popula-
tion with diabetes identified from different regis-
ter sources in Finland over a 16-year follow-up.
▪ We used two indicators of region of residence
that are directly connected to the organisation of
public healthcare for the residents, enabling us
to disentangle the association of each organisa-
tional level with regional variations in complica-
tion rates.
▪ Multilevel models enabled us to capture the hier-
archical nature of the data (health centres nested
in hospital districts), allowing us to analyse the
association more efficiently.
▪ Those with undiagnosed diabetes and diabetes
treated only with diet are missing from our data.
▪ Since we used hospitalisation data to study com-
plications of diabetes, we cannot be sure to what
extent our findings represent a true decrease in
the number of complications or a partial shift of
treatment to ambulatory care.
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decrease has also been reported in many countries
among persons with diabetes.7 8 A similar decrease has
been reported in lower extremity amputations (LEA) in
many countries.9–11 However, the complications still gen-
erate a substantial burden on public health and the
healthcare system.12
Hospitalisations due to ambulatory care sensitive condi-
tions, that is, hospitalisations that could be prevented by
timely and effective primary care interventions, have
under recent years been increasingly used to evaluate
access to and quality of primary care.13 14 Studies have
used slightly different lists of conditions, but have usually
examined three types of conditions: conditions that can be
prevented by vaccination, acute conditions in which hospi-
talisation can be prevented by acute management and
chronic conditions where primary care can prevent later
admissions. The research evidence comes mainly from the
USA,14–17 but some studies have focused on countries
similar to Finland in terms of the healthcare system, such
as Canada14 and the UK.18 There are also a few studies
that have examined the quality of care among persons
with diabetes by using the avoidable hospitalisations
method. These studies have reported hospitalisations due
to complications of diabetes from Taiwan among the adult
population,19 from the USA among veterans20 and elderly
Medicare recipients,21 22 from Canada among persons
with intellectual and developmental disabilities,23 and
among the First Nations population.24 However, these
studies have mainly been based on survey or regional
samples, or speciﬁc population groups and have typically
had relatively short follow-up periods. The Organisation
for Economic Cooperation and Development (OECD)
currently evaluates the quality of diabetes care using four
indicators based on hospital inpatient data, namely hospi-
talisations with uncomplicated diabetes, short-term and
long-term complications of diabetes and LEA among
persons with diabetes.25 We know of one earlier study
examining time trends in regional differences in short-
term complications of diabetes using register data.6 The
Finnish context provides an excellent case for analysing
avoidable hospitalisations, since the public healthcare
system guarantees universal access to care to all residents
according to need irrespective of region of residence or
socioeconomic status. The system is mainly based on tax
revenues and user fees are, in general, low.26
The aim of this register-based study was to examine
hospitalisations due to diabetes-related complications
among the total diabetes population in Finland from
1996 to 2011. We examined trends in diabetes-related
short-term and long-term complications, uncomplicated
diabetes and macrovascular and microvascular complica-
tions including MI, stroke, LEA and ESRD for men and
women separately and with regional differences in them.
METHODS
Population with diabetes
The Diabetes in Finland database was collected in a col-
laborative project by the National Institute for Health
and Welfare (THL), the Social Insurance Institution
(Kela) and the Finnish Diabetes Association. It covers all
persons with diabetes identiﬁed from different register
sources in Finland during 1964−2011 including the
Hospital Discharge and Birth registers (THL), Causes of
Death Register (Statistics Finland), Finnish Kidney
Register and drug reimbursement registers (Kela). For
these persons, data regarding the use of hospital ser-
vices, both public and private (THL), and causes of
death (Statistics Finland) between 1996 and 2011 were
individually linked using the personal identiﬁcation
code unique to each individual. In the data, altogether
176 392 persons with diabetes contributed to 169 765
person years in 1996. In 2010, the numbers had
increased and 385 281 persons contributed to 375 895
person years. We examined hospitalisations among
persons alive with diabetes in the beginning of 1996 and
followed them up until 31 December 2011 or earlier
death. Persons with gestational diabetes only were
excluded from the data. The linkages were performed
by competent authorities and the research group
received anonymised data.
Measurement
We examined hospitalisations due to diabetes complica-
tions using the diagnosis groups used by OECD in asses-
sing quality of care including hospital admissions due to
short-term complications (hypoglycaemic and hypergly-
caemic coma), long-term complications (renal, ocular,
neurological, microvascular and other complications)
and uncomplicated diabetes as the main diagnosis, and
LEA excluding cases associated with trauma.25 We
further examined hospitalisations due to acute MI and
stroke as the main diagnosis as well as the incidence of
ESRD with onset of renal replacement therapy as regis-
tered in the Finnish Kidney Register as an indicator.
Since we wanted to analyse hospital admissions due to
complications among persons with diabetes, hospitalisa-
tions needed to occur after the diagnosis of diabetes or
within 365 days preceding diabetes diagnosis due to a
time lag between the diagnosis and registration of it in
the drug reimbursement register. We considered hos-
pital admissions due to the same complication with
admission dates within 1 day of the discharge day of the
preceding admission as a single admission. There were
altogether 13 097 cases of hospitalisations due to any of
these diabetes-related complications among men in
1996 and the numbers decreased steadily; in 2011, the
number was 9861. Among women, the numbers were
14 596 and 7401, respectively.
We used two indicators of region of residence: ﬁrst,
health centre area (single municipality or cooperation
area of municipalities) that is responsible for organising
primary healthcare for the residents; and second, hos-
pital district (owned by the federations of municipal-
ities), which in Finland is responsible for organising the
public specialist services for the residents. Publicly
funded hospitals produce ca 95% of all specialised
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inpatient services in Finland.26 The municipality of resi-
dence was obtained from the Hospital Discharge
Register for each individual at the time of hospital
admission. Owing to the data protection regulations,
patient data from municipalities with a population
smaller than 5000 persons were merged with data from
neighbouring municipalities with which they cooperated
in some way in organising healthcare, for example,
emergency services. The small hospital district of Åland
was excluded from the analyses due to small numbers.
Other variables included in the analyses were year,
gender and age in 5-year age brackets.
Statistical methods
We calculated rates for avoidable hospitalisations per
10 000 person years adjusting for age using the direct
method, and the total diabetes population of 2011 as
the standard population. We further calculated the sys-
tematic component of variation (SCV) between hospital
districts as a descriptive measure of annual variation in
hospitalisation rates. It relates the number of observed
hospitalisations to those expected in each hospital dis-
trict, given the population structure in terms of year and
age. It is a relative measure that indicates whether the
variation is larger than could be expected by chance.
Likewise, SCVs were calculated between the health
centre areas. We illustrate the variation in regional dis-
persion of complications with the two scatter plots pre-
senting age-adjusted hospitalisation rates among persons
with diabetes per 10 000 person years by health centre
with each dot representing hospitalisation rate at a
single health centre area among men and women
between 2007 and 2011.
Our data also allowed us to examine possible conver-
gence of hospitalisation rates at the hospital district
level. First, we calculated autocorrelations in each of the
complications and hospital districts to study consistency
in hospitalisation rates and their suitability for further
analysis. Next, we performed two-level models for
annual z-scores of the age-standardised hospitalisation
rates in each hospital district and complications adjusted
for polynomial function of time with normally distribu-
ted random intercept and slope terms at the hospital
district level. Z-scores were used for hospitalisation rates
to study the rates from different complications in a com-
parable scale. Multilevel models were applied to capture
the hierarchical nature of the data and polynomial func-
tion of time to capture the general national trend in
each complication. In these models, we examined the
correlation between the random intercept and slope
terms as an estimate of possible convergence in hospital-
isation rates. A statistically signiﬁcant negative correl-
ation was interpreted as a decrease of regional variation
with higher than average random intercepts linked with
a larger than average decrease in random slopes and
vice versa. A similar model was ﬁtted to hospitalisation
rates for all complications simultaneously where polyno-
mial function of time was adjusted for each complication
in order to calculate an estimate for possible general
convergence of hospitalisation rates in diabetic compli-
cations.27 28 In a separate analysis, we examined whether
variation between hospitalisation rates was mainly in the
hospital district or health centre level using three-level
Poisson regression models. In these models, year was
controlled as a continuous variable and age group as a
categorical variable with hospital districts and health
centres nested within hospital districts as random vari-
ables. In order to assess possible changes in the levels of
regional variation, we estimated models separately for
the years 1996−2000 and 2007−2011. The likelihood
ratio test was used to assess the statistical signiﬁcance of
random components in the models. In all the analyses,
separate models were calculated for men and women
and for each of the complications.
RESULTS
Among both men and women, hospitalisation rates were
largest for uncomplicated diabetes and long-term com-
plications of diabetes (ﬁgure 1). The LEA rates, and
especially ESRD rates, were relatively low. The rates
among persons with diabetes (per 10 000 person years)
for LEA were 82 among men and 41 among women in
1996, and for ESRD 11 among men and 6 among
women in 1996. Hospitalisations due to the diabetes-
related complications, both long-term and short-term,
and uncomplicated diabetes decreased by ca 80%
during the study period. Hospitalisations due to LEA,
MI and stroke decreased by ca 50%, and hospitalisations
due to ESRD decreased by ca 30% during the study
period among both genders.
Table 1 shows per complication the hospitalisation
rates for ﬁve complications in 1996, 2004 and 2011 and
the SCV between hospital districts and between health
centre areas. The SCV between hospital districts was, in
general, small, and larger in hospitalisations due to
short-term complications of diabetes, especially among
women (0.06–0.13), while among men the variation was
0.02–0.06. In relative terms, the SCV diminished only in
MI among women and in stroke among men, which
would suggest that the hospital district rates for most of
the complications would not converge.
The SCVs were, in general, much larger when examin-
ing health centre areas compared with hospital districts.
The SCV was especially large in short-term complica-
tions of diabetes both among men (0.43–0.45) and
among women (0.42–0.45), and it remained relatively
stable throughout the study period. The SCV only dimin-
ished in stroke among both genders and in MI among
men, suggesting that health centre area rates would not
converge either.
We then inspected whether hospital districts were con-
sistently above or below the national trend in each of
the complications. Since the autocorrelations in hospital-
isation rates due to LEA and ESRD were relatively small
and, probably due to small numbers, varied between
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Figure 1 Age-adjusted rates of hospitalisations due to complications of diabetes (per 10 000 person years) among men and
women with diabetes in 1996–2011 in Finland.
Table 1 Hospitalisation rate (per 10 000 person years in population at risk), and systematic component of variation between
hospital districts (SCVHD) and health centre areas (SCVHC) in diabetes-related complications in 1996, 2004 and 2011 in
Finland
Year
Men Women
1996 2004 2011 1996 2004 2011
Short-term complications
Rate 95 67 33 71 58 27
SCVHD 0.021 0.054 0.060 0.113 0.056 0.129
SCVHC 0.431 0.399 0.451 0.445 0.416 0.422
Long-term complications
Rate 486 261 116 419 181 74
SCVHD 0.017 0.042 0.018 0.017 0.022 0.048
SCVHC 0.207 0.232 0.244 0.285 0.271 0.318
Uncomplicated diabetes
Rate 572 295 101 579 272 84
SCVHD 0.021 0.037 0.040 0.020 0.009 0.068
SCVHC 0.159 0.167 0.240 0.125 0.165 0.234
Stroke
Rate 305 241 125 191 142 93
SCVHD 0.033 0.021 0.007 0.013 −0.001 0.068
SCVHC 0.290 0.169 0.173 0.229 0.206 0.191
Myocardial infarction
Rate 243 216 121 177 141 69
SCVHD 0.008 0.012 0.014 0.015 −0.006 0.008
SCVHC 0.240 0.254 0.160 0.189 0.159 0.181
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hospital districts suggesting non-consistency in time, they
were excluded from further analyses. The rest of the
hospital district autocorrelations averaged over the con-
ditions varied between 0.24 and 0.71 with an average of
0.43 among men, and between 0.38 and 0.70 with an
average of 0.54 among women. These results suggest
that the regional patterns of hospitalisations were rather
consistent in time. The average autocorrelation per con-
dition varied between 0.30 (MI) and 0.63 (uncompli-
cated diabetes) among men and between 0.33 (stroke)
and 0.72 (uncomplicated diabetes) among women.
In multilevel analysis, the overall correlation (includ-
ing all complications) between hospital district inter-
cepts and slopes in time was −0.72 (p=0.0003) among
men and −0.99 (p<0.0001) among women, indicating
that the overall hospital district variation in hospitalisa-
tions due to these ﬁve categories of complications dimin-
ished, suggesting convergence. When analysing each
complication separately (table 2), the decline was signiﬁ-
cant in all the other groups (p<0.0001); it was only in
the hospitalisations due to short-term complications of
diabetes that the decline in hospital district variation was
not statistically signiﬁcant (p=0.397) among men. All the
correlations were negative, strongly suggesting decreasing
hospital district variation during the study period.
Figure 2 presents the health centre area distribution
of hospitalisations due to short-term and long-term com-
plications of diabetes in 2007−2011 as examples of large
and small regional variation in complications. Each dot
represents a health centre area. In the ﬁgure for short-
term complications, most of the health centres are close
to the mean among both men and women and there
are few outliers. In hospitalisations due to long-term
complications of diabetes, the variation was much larger,
especially among men, and only some of the health
centres were close to the mean. Additionally, the area
covering 75% of the observations was larger among men
compared with women.
Finally, we examined on which regional level (health
centre level vs hospital district level) the variation was
mainly distributed in each of the ﬁve complications at
the beginning (1996−2000) and end (2007−2011) of the
study period. We examined these two periods due to the
magnitude of change in complication rates during the
study period (table 3). At the beginning of the study
period, variance in all complications except MI among
both men and women was predominantly distributed at
the health centre level, suggesting relatively large differ-
ences between health centres in hospitalisation rates.
However, hospital district-level variance was also statistic-
ally signiﬁcant in all complications except short-term
complications among men and stroke among women.
In MI, the variance was equally distributed among
both regional levels, both of which were also statistically
signiﬁcant. In 2007–2011, while the variance estimates
appeared to be somewhat lower compared with the
beginning of the study period, the variance was still pre-
dominantly distributed at the health centre level except
for MI among both genders.
DISCUSSION
Overview of the main results
This study examined trends in the incidence of hospitali-
sations due to diabetes-related complications and
regional differences in them from 1996 to 2011. In
general, there was a steep decline in the incidence of
hospitalisations due to diabetes-related complications
among persons with diabetes during the study period.
The decline was relatively small in ESRD. Instead, the
rates of hospitalisations for short-term and long-term
complications of diabetes as well as uncomplicated dia-
betes declined by about 80%. These results are in line
with earlier evidence concerning speciﬁc complications
from Finland9 and elsewhere.5 11 Several factors can
explain the major change. Hypoglycaemia is treated
more and more often in ambulatory care,29 whereas car-
diovascular risk factors are treated more actively,30 and
threatening symptoms are investigated and treated
earlier before major complications appear.
We further found regional variation in each of the
complications studied. These variations diminished
during the study period. Earlier studies from other
countries have also reported regional differences in
complications of diabetes31 and diminishing of differ-
ences in time.6 Several potential reasons for the regional
variation corresponding with the results of the current
study have been suggested in earlier studies, including
regional differences in the disease prevalence, sociode-
mographic characteristics of the patient population and
access to and quality of primary care.6 32–34 Our data did
not contain information about the socioeconomic pos-
ition of the population with diabetes. Further studies are
needed to examine the sociodemographic characteristics
of the population with diabetes in order to ﬁnd out
whether these contribute to the differences.
Finally, we found that in most complications, the main
part of the variance came from the health centre level.
This suggests variation between health centres in the
primary care of persons with diabetes and in prevention
of complications. Some health centres had a shortage of
general practitioners during the study period, which may
have resulted in less active treatment of diabetes. As in all
Table 2 Multilevel model-based correlation between
hospital district intercepts and slopes in time between
1996 and 2011
Men Women
Short-term complications −0.20 NS −0.77***
Long-term complications −0.88*** −0.98***
Uncomplicated diabetes −0.91*** −0.98***
Stroke −0.91*** −0.94***
Myocardial infarction −0.79*** −0.87***
***p<0.0001.
NS, non-significant at the p<0.05 level.
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quality challenges, the attitudes of physicians and nurses
also play a role when deciding how aggressive the treat-
ment of risk factors is. While the variance between health
centres appeared to decline during the study period,
there were still differences between health centres at the
end of the study period. The fact that there is no regular
reporting system telling the health centre personnel how
they are accomplishing in the risk reduction of diabetes
complications, may have contributed to the large vari-
ation found in our study. Thus, a regular reporting system
might inﬂuence the activity of risk reduction.
During the study period, Finland launched a national
development programme for the prevention and care of
diabetes (DEHKO 2000–2010) aiming to prevent type 2
diabetes and to improve the quality of diabetes care. It
also focused on prevention of complications of diabetes.
While the programme was national, part of the activities
were launched at the hospital district level. Our study
cannot directly examine whether the decline in compli-
cation prevalence was due to the prevention pro-
gramme, but the results suggest that the development is
in line with the goals of the programme, although in
our study the decrease in hospitalisation rates started
before the launch of the programme and was relatively
stable during the whole study period, as suggested
by the relatively high hospital district autocorrelations
found in our study.
Methodological considerations
Our data and indicators of complications were based on
several large administrative registers which have, in
general, been estimated to have good-to-excellent valid-
ity.35 36 When interpreting the results, it needs to be
taken into account that some of the indicators used in
the study overlap. For example, long-term complications
of diabetes include microvascular complications which
Figure 2 Health centre area distribution of hospitalisations due to short-term and long-term complications of diabetes among
men and women with diabetes in 2007–2011 in Finland, age-adjusted rates per 10 000 person years.
Table 3 The distribution of variance in hospitalisations due to five diabetes-related complications to health centre (HC) and
hospital district (HD) level in Finland in 1996–2000 and 2007–2011 (Poisson multilevel models controlling for year as
continuous variable and age as categorical variable)
Complication Men Women
Period 1996–2000 HC level HD level HC level HD level
Short-term complications 0.122***† 0.002 NS 0.241*** 0.034**
Long-term complications 0.096*** 0.017*** 0.139*** 0.035***
Uncomplicated diabetes 0.106*** 0.063*** 0.103*** 0.057***
Stroke 0.064*** 0.010*** 0.040*** 0.001 NS
Myocardial infarction 0.020*** 0.029*** 0.031*** 0.028**
Period 2007–2011
Short-term complications 0.110*** 0.046** 0.225*** 0.029 NS
Long-term complications 0.059*** 0.023*** 0.087*** 0.045***
Uncomplicated diabetes 0.111*** 0.099*** 0.143*** 0.070***
Stroke 0.064*** 0.004*** 0.042*** 0.002 NS
Myocardial infarction 0.021*** 0.028*** 0.039*** 0.038***
†The significance of variance at each level tested by the likelihood ratio test. ***p<0.001, **p<0.01, *p<0.05.
NS, non-significant.
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overlap with amputations and ESRD. Since we used hos-
pitalisation data, that is, complications observed in spe-
cialised care, we cannot be sure whether our ﬁndings
represent a true decrease in the number of complications
or part of their treatment just shifting outside hospitals
during the study period. For example, milder complica-
tions are treated further in primary care, and short-term
complications by ﬁrst-aid personnel, decreasing the need
for hospitalisations. A strength of the study is that we
could examine preventable complications among the
total diabetes population of the country during a 16-year
period. However, those with diabetes treated only with
diet (and not hospitalised or died during the study
period), and undiagnosed cases are missing from the
data. We examined persons with type 1 and type 2 dia-
betes together, since type 1 consists only of 10–15% of
the total population with diabetes in Finland and could
not be analysed separately due to small numbers.
Additionally, diabetes type cannot unambiguously be
deﬁned using register data only. Since the focus of our
study was diabetes-related avoidable hospitalisations and
regional variations in them, we did not take into account
factors related to disease history or the existence of mul-
tiple complications among persons with diabetes. The
rate for multiple admissions was 851/10 000 person years
among men in 1996 and 192/10 000 person years in
2011. Among women, the numbers were 632 and 115.
Among both genders, approximately half of these were
due to the same reason and half due to different reasons.
The Finnish diabetes population increased rapidly
during the study period. This is likely to be partly due to
an increase in overweight and sedentary lifestyle.
Simultaneously, early detection and treatment of dia-
betes is likely to have improved, leading to a larger part
of diabetes being diagnosed and at a milder stage
towards the end of the study period. Further, survival
rates have increased in many of the complications. To
examine whether the decrease in the incidence of hospi-
talisations due to diabetes-related complications is
mainly due to the increase in population with diabetes,
we performed a sensitivity analysis examining national
trends in the complications studied in the total Finnish
population. These hospitalisation rates also showed a
clear downward trend among the total population, but
the trend was less steep compared with that within the
diabetes population. For example, the decrease was ca
25% among both genders in stroke (vs 50% among
the population with diabetes) and 10% among men
(vs 50%) and 29% (vs 50%) among women in MI
among the population during the study period. This
suggests that part of the decrease has to do with the
growing and ageing of the population with diabetes in
addition to improvements in complication prevention.
CONCLUSIONS
Our study suggests that the prevention of complications
among persons with diabetes has improved in Finland
between 1996 and 2011. Our results concerning larger vari-
ation in the health centre area suggest that regional differ-
ences exist especially in primary care, which is mainly
responsible for management of diabetes and prevention
of complications in Finland. Both the convergence of hos-
pital district variation and the apparent diminishing of
health centre level variation suggest that the prevention
of complications has become more uniform throughout
the country.
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